Načítá se...
Inhibition of pSTAT1 by tofacitinib accounts for the early improvement of experimental chronic synovitis
BACKGROUND: In order to gain insight into the early effects drawn by JAK inhibitors on intra-joint JAK/STAT-dependent signaling, we sought synovial activation of STATs and their end-products, along with their modification with tofacitinib (TOFA), at flare-up in antigen induced arthritis (AIA). New Z...
Uloženo v:
| Vydáno v: | J Inflamm (Lond) |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6352431/ https://ncbi.nlm.nih.gov/pubmed/30728752 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12950-019-0206-2 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|